When one of the world’s leading pharmaceutical companies, headquartered in the United States, decided to move to a different safety system, it was quickly realized this was no mere software switch. The move represented an end-to-end transformation of their pharmacovigilance ecosystem—touching data, processes and governance.
The two systems differ significantly in architecture, functionality, and interface, requiring robust change management, extensive training, and strong project governance.
A successful transition demands re-evaluating business processes from the ground up. For many organizations, this is an ideal opportunity to optimize configuration, streamline operations, and eliminate legacy inefficiencies.
Scope
Simplify, centralize and streamline processes, align operational procedures and safety system configuration and maintenance.
Project goals
- Review current state processes and procedures
- Conduct review sessions with internal and external stakeholders
- Map owners and stakeholders to the process flow
- Identify and summarize areas of improvement/opportunities
- Develop the future state model, RACI & strategic roadmap
- Recommend options and finalize areas of opportunities
- Develop overall project plan for implementation
Benefits
The transformation unfolded in three phases:
Benefits were substantial:
- Configuration changes were reduced, cutting down both time cycles and vendor costs
- Delays in implementation and the need for contingency plans dropped significantly, improving compliance readiness
- Verification and quality checks became faster and more reliable
- System maintenance was simplified, streamlined through implementation of a Company-wide single place of reference
- Onboarding newly acquired products became more efficient, thanks to standardized processes.
Conclusion
What began as a technology change evolved into a catalyst for operational excellence, empowering the organization to leverage the new safety system capabilities to their fullest.
By combining thoughtful configuration, meticulous data migration, and process optimization, organizations can unlock the full potential of technology while future-proofing their pharmacovigilance operations.
Conclusion
- This case study demonstrates that introducing Nextrove Progressive GFA in pharmacovigilance follow-up is a strategic transformation.
- By integrating intelligent case analysis, automated reminders, customizable queries, and seamless response ingestion, Nextrove Progressive GFA helps organizations to reduce operational burden, improve case quality, strengthen compliance, and achieve measurable ROI.
- In an era of increasing regulatory scrutiny and rising case volumes, Nextrove Progressive GFA represents a critical enabler of sustainable, high-quality pharmacovigilance operations.